KCT0003598进行中（未招募）未知
Does measurement of fecal calprotectin levels help distinguish intestinal tuberculosis, Crohn’s disease, and ulcerative colitis?
Eulji University Hospital0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational Study
入排标准
- 年龄范围
- 20(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •We retrospectively reviewed the medical records of over 20 years old patients with renal tuberculosis, Crohn 's disease, and ulcerative colitis treated with calprotectin in the stool.
排除标准
- •Under 20 years
研究者
相似试验
已完成
不适用
Relevance of fecal calprotectin as a biomarker to predict the outcome of Adalimumab therapy in Ulcerative Colitis patients.lcerative ColitisJPRN-UMIN000022104Hyogo College of Medicine, Department of Inflammatory Bowel Disease, Division of Internal Medicine54
招募中
Unknown
Study on the usefulness of fecal calprotectin in ulcerative colitis and the relevance of other biomarkerslcerative colitisJPRN-UMIN000052832Ehime University150
已完成
不适用
Can fecal calprotectin be a predictive marker for refractoriness in patients with ulcerative colitis ?lcerative colitisJPRN-UMIN000024146Showa University, School of Medicine100
已完成
不适用
The value of faecal calprotectin (CPT) in monitoring the response to treatment of patients with inflammatory bowel diseaseInflammatory bowel diseaseDigestive SystemCrohn's disease [regional enteritis]ISRCTN81965907Department of Health (UK)80
招募中
不适用
The use of fecal calprotectin in detecting immunotherapy induced colitis and feasibility for the use of immunohistochemical markers in patients receiving checkpoint inhibitors’- a pilot studycolitisNL-OMON25248KI-AV50